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Abstract
Alternative splicing generates protein diversity and allows for post-transcriptional gene regulation. Estimates suggest that
10% of the genes in Caenorhabditis elegans undergo alternative splicing. We constructed a splicing-sensitive microarray to
detect alternative splicing for 352 cassette exons and tested for changes in alternative splicing of these genes during
development. We found that the microarray data predicted that 62/352 (,18%) of the alternative splicing events studied
show a strong change in the relative levels of the spliced isoforms (.4-fold) during development. Confirmation of the
microarray data by RT-PCR was obtained for 70% of randomly selected genes tested. Among the genes with the most
developmentally regulated alternatively splicing was the hnRNP F/H splicing factor homolog, W02D3.11 – now named hrpf-
1. For the cassette exon of hrpf-1, the inclusion isoform comprises 65% of hrpf-1 steady state messages in embryos but only
0.1% in the first larval stage. This dramatic change in the alternative splicing of an alternative splicing factor suggests a
complex cascade of splicing regulation during development. We analyzed splicing in embryos from a strain with a mutation
in the splicing factor sym-2, another hnRNP F/H homolog. We found that approximately half of the genes with large
alternative splicing changes between the embryo and L1 stages are regulated by sym-2 in embryos. An analysis of the role
of nonsense-mediated decay in regulating steady-state alternative mRNA isoforms was performed. We found that 8% of the
352 events studied have alternative isoforms whose relative steady-state levels in embryos change more than 4-fold in a
nonsense-mediated decay mutant, including hrpf-1. Strikingly, 53% of these alternative splicing events that are affected by
NMD in our experiment are not obvious substrates for NMD based on the presence of premature termination codons. This
suggests that the targeting of splicing factors by NMD may have downstream effects on alternative splicing regulation.
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Introduction
Alternative splicing (AS) is the process by which a single pre-
mRNA is spliced in different ways to generate multiple mRNA
transcripts. This process represents an important mechanism for
post-transcriptional regulation of gene expression [1]. It has been
estimated that as many as 70% of human genes undergo AS
[2,3]. For Caenorhabditis elegans, it has been proposed that ,10% of
genes undergo alternative splicing [4]. Alternative splicing is
known to be regulated in tissue-specific, cell-cycle, stress-
responsive, hormone-responsive and developmental manners
[5–7]. The regulation of AS is achieved by an interplay between
proteins known as trans-acting splicing factors, that can act as
activators or repressors, and intronic or exonic RNA sequences
known as cis-elements, that can also be labeled as enhancers or
silencers. With the development of splicing-sensitive microarrays
[8] there has been a recent increase in the information about
global regulation of splicing in yeast, flies, mice and humans (for a
review see [9]).
The establishment of C. elegans by Sidney Brenner as a model
system for the study of neurobiology and development has led to
many important discoveries and advances in biology (for a review
of global studies see [10]). Analysis of heterochronic genes led to
the discovery of the first microRNAs [11] and studies in this
organism led to the discovery of the phenomenon of RNAi [12]. In
1998, C. elegans became the first animal to have its genome fully
sequenced [13]. The understanding of the complete cell lineage of
the animal has led to important insights into development [14].
Even with the wealth of genomic information available about C.
elegans, there is currently no information about the global
regulation of alternative splicing during worm development. Some
examples of AS events regulated during C. elegans development
have been described [15–17]. An important question remains as to
whether alternative splicing has an important role in the
development of this animal. For example, in a global study of
alternative splicing it was shown that in Drosophila as much as
46% of the genes show changes in patterns of exon expression
during development, suggesting regulated alternative splicing or
alternative promoter usage for a high percentage of the genome
[18]. In particular, RNAi experiments of several splicing factors
showed that some are necessary for worm development while
others have redundant functions [19–22]. While there is currently
no evidence of their targets, it is possible that some splicing factors
might function as stage-specific regulators of alternative splicing.
This regulation might trigger important changes in diverse cellular
processes.
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premature termination codons (PTCs) caused by mutation has
been described in this organism, and mutations in genes that affect
this process have been described as suppressors with morphoge-
netic effects on genitalia (smg) genes [23,24]. It has been shown that
there is a dynamic interplay between alternative splicing and
NMD [25–27]. While it is known that the inclusion or exclusion of
cassette exons changes important functions for diverse proteins, it
has also been suggested that the inclusion/skipping events also
help the cell to regulate gene expression. Perhaps a gene can be
turned off not by turning off transcription but by changing its
splicing to produce an isoform of the mRNA that is a target for
NMD. This scheme might allow for regulation of individual genes
in polycistronic operons in C. elegans in which several genes share
the same promoter [28]. Thus individual genes in the operon,
which could not be regulated individually at the level of
transcription, might be regulated at the level of alternative splicing
leading to changes in individual mRNA stability. In mammalian
cells NMD is known to follow the 55 nucleotides rule, where a
PTC needs to be at least 55 bp upstream of the last splice site in
order to elicit NMD [29]. It has recently been shown that NMD in
C. elegans is splicing independent in that it can be elicited by
premature termination codons even in intronless genes [30]. This
difference in the action of NMD makes the identification of native
NMD targets in C. elegans more complex.
To add another layer of complexity, the regulation of several
splicing factors is known to be achieved by complex interactions
that include both alternative splicing and NMD. This was shown
originally in C. elegans [27] and more recently found in vertebrates
[25,26]. It was demonstrated initially that two C. elegans SR protein
splicing factors contain exons with premature termination codons
(PTCs) that target a particular isoform to NMD [27]. In this
regard C. elegans presents an interesting model for the study of
NMD regulation due to the viability of mutants that are defective
in NMD pathways [23]. An important link between NMD and
development has been recently shown for Drosophila, with the
discovery that NMD is highly active during development and is
required for the proper expression of dozens of genes as well as for
larval viability [31]. However, the link between AS and NMD
during development remains to be studied.
In this paper we investigate the regulation of AS during C.
elegans development, from embryos to gravid adults, and passage
through each of the four different larval stages. To do this we
developed a splicing-sensitive microarray with features for
detection of AS for 352 cassette exons. We show that there is a
global regulation of alternative splicing during development, with
several events presenting significant differences in AS between
different stages. We focus our analysis on events with dramatic
changes in AS (greater than four-fold changes in spliced isoform
ratios). The highest number of significant splicing changes
detected occurred at the step between embryos and the subsequent
L1 stage, with 14 AS events highly regulated in this transition. One
of the events with the highest change occurs in the W02D3.11
gene, which encodes the C. elegans ortholog of the human hnRNP
H and F splicing factor proteins, which we have named hrpf-1. The
skipping isoform of hrpf-1 includes a PTC that targets a fraction of
the messages with this isoform to NMD. However, the exon
inclusion isoform shows a dramatic change at the level of splicing
at the transition from embryos to L1, with 65% of steady state
messages in embryos including this exon but with only 0.1% of
messages including this exon in L1s. Global analysis of splicing
during development shows the complex nature of this regulation
and provides initial clues towards de-convoluting these regulatory
networks. We also provide evidence that more than half of the
alternatively spliced isoforms of messages that are differentially
stabilized in NMD mutant strains appear not to be direct
substrates for NMD, suggesting the possibility that NMD
regulation of splicing factors may influence downstream alterna-
tive splicing events.
Results
Microarray Analysis of AS During Development
We previously reported the identification of a group of 449 C.
elegans genes with EST or mRNA evidence of having alternative
cassette exons [32]. In order to study the regulation of alternative
splicing during C. elegans development we created a splicing-
sensitive microarray with features to detect alternative splicing of
302 of these cassette exons (see Methods and Figure 1 for details).
Although the coverage by ESTs in C. elegans is limited (,300,000
ESTs [33]), algorithms to predict alternative splicing events
without previous expression evidence have been reported
[4,33,34]. To further expand the set of AS events detected by
our array, we incorporated 50 predictions of cassette exons with
AS, based on the RASE algorithm. RASE is a support vector
machine-based classifier that identifies known exons with AS
potential [34]. In total, our platform has features for the detection
of the AS of 352 cassette exons.
RNA from six different developmental times was obtained from
large-scale synchronized cultures; embryo, L1, L2, L3, L4 and
gravid adults. To study the changes in alternative splicing during
development, we determined the AS ratios for each cassette exon
at each developmental stage compared to embryo (set arbitrarily
as the reference) (Figure 1B). To do this we calculated the log
ratios for each one of the probes (constitutive 1, constitutive 2,
alternative and junction) (Figure 1A) between embryo and each of
the other five stages. From this embryo vs. stage AS ratio we
calculated the AS ratios between all possible pairs of stages to
detect all the AS events that changed greater than 62.0 in log
scale. For example: for F25C8.3 the emb vs. L1 AS ratio is 1.94
and the emb vs. adult AS ratio is 21.15 so the L1 vs. adult AS
Author Summary
Alternative splicing is a mechanism for generating more
than one messenger RNA from a given gene. The
alternative transcripts can encode different proteins that
share some regions in common but have modified
functions, thus increasing the number of proteins encoded
by the genome. Alternative splicing can also lead to the
production of mRNA isoforms that are then subject to
degradation by the nonsense-mediated decay pathway,
thus providing a mechanism to down-regulate gene
expression without decreasing transcription. Examples of
cell type-specific, hormone-responsive, and developmen-
tally-regulated alternative splicing have been described.
We decided to measure the extent of developmentally
regulated alternative splicing in the nematode model
organism Caenorhabditis elegans. We developed a DNA
microarray that can measure the alternative splicing of 352
cassette exons simultaneously and used it to probe
alternative splicing in RNA extracted from embryos, the
four larval stages, and adults. We show that 18% of the
alternatively spliced genes tested show .4-fold changes in
alternative splicing during development. In addition, we
show that one of the most regulated genes is itself a
splicing factor, providing support for a model in which a
cascade of alternative splicing regulation occurs during
development.
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in Figure 1B. For the microarray analysis we applied a loop design
with dye-swaps so that each developmental stage will have four
different hybridizations corresponding to two different RNA dye
labelings (Figure 1C), comprising a total of 12 hybridizations [35].
We identified 62 cassette exons with AS ratios between any two
developmental stages of greater than 62.0 in log scale (Table 1
and Table S1). These data indicate a greater than 4-fold change in
the relative abundance of stable alternatively spliced isoforms
containing these cassette exons during the course of development.
Clustering of these AS events shows a group of exons that are
highly included in embryos (10 exons), another group with low
embryonic inclusion (16 exons) and smaller clusters that primarily
include the exons at different larval stages (Figure 2). While several
of the changes are gradual between subsequent stages, some events
present drastic changes between stages (Figure 2).
In order to confirm these differences in AS we analyzed, by
reverse transcription followed by polymerase chain reaction (RT-
PCR), the changes in the relative abundance for 14 randomly
selected alternative events from the 32 with the highest changes
between embryo and any other stage. From this group of
randomly selected events we detected AS ratios that correlate
with the microarray for 10 events; two did present changes but in
disagreement with the microarray, while two showed no changes
according to the RT-PCR (Figure 3). This gives an array
validation fraction of 10/14 (,71% with a confidence interval
of 618% for the rest of the AS events with .4-fold changes) for
our splicing sensitive microarray. This validation rate is similar to
one observed for a comparable microarray platform for detecting
AS changes in human breast cancer, in which validation of a
subset of array results by RT-PCR confirmed ,75% of the events
predicted by the microarray [36]. Among the cassette exons for
which the array data were validated by RT-PCR is topoisomerase-
1( top-1), a gene that was previously shown to have an embryo-
specific exon [15].
Several of the RT-PCRs show additional bands in addition to
the predicted isoforms. For tag-253 we sequenced one an
additional band and identified it as a novel isoform for which
there was no previous EST or mRNA evidence. This isoform,
which represents ,65% of the transcripts, derives from skipping
of two exons. One of them is the one targeted for detection by
the microarray probes, but the other was considered a
constitutive exon in the current gene model at Wormbase. This
example shows evidence that in some cases, the disagreement
between the microarray AS ratios and the ones from the RT-
PCR validation can be due to the generation of novel isoforms
by alternative splicing that are not considered in the current
gene models. Seven of the 62 cassette exons with .4f o l d
changes in their relative levels during development were novel
cassette exons predicted to be alternatively spliced by the RASE
algorithm [34] (Table 1 and Figure S1). These changes in levels
during development help to confirm that these are indeed
alternative cassette exons. In general, these results also validate
the RASE approach to alternative splicing prediction; roughly
the same fraction of cassette exons showing .4-fold changes in
relative usage during development were found in those
predicted by RASE (7/50), as for known cassette exons (55/
302).
Alternative Splicing Coupled to NMD
The set of genes showing large changes in alternative splicing
during development includes some well characterized genes (i.e.
unc-16, unc-43, top-1) and several putative proteins of unknown
function (i.e. D1046.1, F28E10.1) (Table 1). Among the
characterized genes are two nuclear hormone receptors (nhr-64
and nhr-65). Nhr genes belong to a family of transcription factors
known to have an important role in development [37], of which
270 members are found in the C. elegans genome [38]. We noted
that the alternative spliced exon of nhr-65 contains a premature
termination codon (PTC) that possibly targets this isoform to
NMD. Embryos have a higher rate of inclusion for the PTC
containing exon of nhr-65, opening the possibility that AS coupled
to NMD is important for determining the relative steady-state
levels of the spliced isoforms of nhr-65 in embryos.
Figure 1. Splicing sensitive microarray design. (A) general outline of the probe design used to detect AS of cassette exons; probes were
designed as follows: ‘‘alt probe’’ to detect the cassette exon and thus the inclusion isoform, ‘‘junction probe’’ to detect the splice junction formedi n
the skipping isoform, and at least two different constitutive probes, c1 and c2, to detect levels of gene expression. (B) AS ratio calculation; (C) loop
design to compare all six different time points, each arrow correspond to a direct comparison including the dye-swap experiment (for example,
embryo vs. L1 and L1 vs. embryo hybridizations were performed), for a total of 12 microarray hybridization experiments.
doi:10.1371/journal.pgen.1000001.g001
AS Regulation During C. elegans Development
PLoS Genetics | www.plosgenetics.org 3 2008 | Volume 4 | Issue 2 | e1000001Table 1. Top changes in AS during development.
Gene
Stages with furthest
differences
AS ratio
(log scale)
RT-PCR
confirm
Cassette exon a
Multiple of 3?
AS ratio (N2 emb
vs. smg-1 emb)
AS ratio (N2 emb
vs. smg-2 emb)
gip-1 Emb vs. L4 24.74 no 20.09 20.78
mbk-2 Emb vs. Ad 24.23 - no 1.17 0.28
gsy-1 (RASE) Emb vs. L1 23.75 yes 0.06 1.37
F38B7.1 Emb vs. L1 23.26 + no 20.49 0.78
tag-253 Emb vs. L4 23.16 + no 0.48 0.75
nhr-64 Emb vs. L4 22.84 yes 1.81 20.45
T19A5.3 Emb vs. L1 22.76 + no 0.64 0.93
F53E4.1 (RASE) Emb vs. L4 22.74 yes 20.25 21.19
K08E7.5 L1 vs. L4 22.69 no 20.17 21.93
ser-7 Emb vs. L3 22.64 yes 21.29 21.19
unc-43_2 Emb vs. L1 22.63 yes 22.23 0.21
ketn-1 L1 vs. Ad 22.59 yes 0.36 0.48
sma-9 Emb vs. Ad 22.51 + yes 0.46 0.46
F54A3.3 Emb vs. L3 22.44 yes 20.40 21.1
gly-6 Emb vs. L3 22.33 yes 20.92 1.32
nhx-5 Emb vs. L4 22.32 no 21.19 1.77
rme-8 L4 vs. Ad 22.32 yes 20.53 20.57
rbf-1 (RASE) L1 vs. L4 22.31 no 21.25 21.54
unc-104 Emb vs. L1 22.28 - no 20.04 0.49
F43E2.3 (RASE) L2 vs. Ad 22.25 no 0.19 20.16
npp-1 L2 vs. Ad 22.21 yes 20.27 20.17
spk-1 L1 vs. L4 22.19 no 20.97 21.1
gly-4 Emb vs. Ad 22.18 no 0.24 0.28
lat-1 L1 vs. Ad 22.16 no 20.23 0.44
T04C9.1 L1 vs. Ad 22.12 yes 0.60 0.49
egl-4 Emb vs. Ad 22.09 yes 20.14 1.15
pqn-70 L1 vs. Ad 22.08 no 21.64 0
H14E04.2 Emb vs. L4 22.06 yes 2.52 2.24
D1046.1 Emb vs. L3 22.05 no 1.19 1.75
F42A9.1 L1 vs. L4 22.04 yes 0.15 20.49
frm-1 L1 vs. Ad 22.03 yes 20.92 20.9
F46E10.1 (RASE) L1 vs. L4 22.03 yes 21.16 20.89
scd-1_2 L1 vs. L4 2.00 yes 0.07 1.49
D2024.5 L1 vs. Ad 2.06 yes 1.07 0.4
C55F2.1 L1 vs. L2 2.07 yes 2.02 0.61
C34F11.3 L2 vs. L4 2.09 yes 0.19 0.94
F29B9.2 Emb vs. Ad 2.11 - yes 1.23 1.46
gpdh-2 L2 vs. L4 2.14 yes 0.19 20.2
F28E10.1 (RASE) Emb vs. L1 2.15 no 0.88 21.06
F33D11.9 Emb vs. L4 2.15 + yes 20.68 21.01
exoc-8 L2 vs. Ad 2.16 no 20.30 20.83
pme-3 L3 vs. Ad 2.19 yes 20.21 20.75
unc-16_2 Emb vs. L1 2.22 + yes 20.26 1.39
gcy-31 Emb vs. L1 2.27 no 20.98 21.68
Y37E3.17 L2 vs. Ad 2.33 yes 20.34 20.39
alp-1 L1 vs. Ad 2.35 yes 1.37 0.38
F47B7.2 L1 vs. Ad 2.36 no 20.91 20.79
twk-31 Emb vs. L1 2.41 - no 0.73 0.58
top-1 Emb vs. L1 2.42 + yes 0.29 0.45
AS Regulation During C. elegans Development
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cassette exons (those not divisible by three) have a higher tendency
to disrupt protein domains and to create possible substrates for
NMD [39]. Almost half (42%) of the cassette exons with high
differences in alternative splicing are not a multiple of three in
length. Therefore, inclusion or skipping of these exons by
alternative splicing is likely to alter the reading frame for the rest
of the transcript, possibly disrupting protein domains and leading
to in-frame PTCs (Table 1). While this number (42%) seems high,
it is not significantly different (Fisher Exact test, P=0.42) from the
number of exons that are not a multiple of three in the whole set of
exons considered for the microarray analysis, where 34% are not a
multiple of three (see Table S3).
Given the high proportion of cassette exons undergoing large
changes in alternative splicing during development that are not
multiple of three, and that some alternative cassette exons contain
PTCs, we studied how many of the splicing changes detected are
indeed linked to NMD in embryos. To do this, we used the
splicing-sensitive microarray to detect the levels of splicing in two
strains carrying mutants in NMD genes, smg-1(r861) and smg-
2(e2008). SMG-1 is a member of the family of phosphatidylinositol
3-kinase (PI3K)-related protein kinases (PIKKs) and is required for
NMD [40]. SMG-1 phosphorylates SMG-2/UPF1, the key
component of the NMD pathway, and this phosphorylation is
required for NMD to occur [41]. RNA was prepared from smg-1
and smg-2 mutant embryos and tested on the array in comparison
to WT embryo RNA. We found that for 4/62 (,6%) of the events
with high changes during development, the steady state levels of
the various isoforms are strongly affected by NMD (greater than 4-
fold changes) (Table 1).
In order to see whether there are any specific effects for
mutation of either of these two components of the NMD pathway
on message stability, we compared the results obtained when
comparing WT against smg-1 or smg-2 embryo samples (Table 2).
28 different mRNAs showed .4 fold changes in the relative levels
of the different isoforms in an NMD mutant background vs. wild
type. There are only three genes that show a significant difference
in alternative splicing between the two different smg gene mutants.
Two of these (akt-1 and C27A7.5) were further analyzed by RT-
PCR, and we found no differences in AS according to RT-PCR,
so the differences detected by the microarray are false negatives for
the smg-2 sample. This result indicates that the SMG-1 kinase does
not have detectable effects on message stability outside of its
interaction with its known target, SMG-2.
NMD is known to regulate the mRNA stability of splicing factors
isoforms, and in this way creates another level of complexity for
determining the relative steady state levels of alternative splicing
isoforms in an NMD mutant. This had already been noted for two
of the SR protein splicing factors (rsp-4 and rsp-6) [27] one of which
did show changes in splicing in a NMD mutant in the present
analysis (Table 2). The differences in alternative splicing between
wild type and NMD mutant worms may be due to direct effects on
thestability ofthetranscripts (NMD), ortoindirect effects dueto the
mis-regulation of splicing factors.
In general we found that ,8% of the 352 studied AS events had
greater than 4-fold changes in the relative levels of alternatively
spliced isoforms in embryos in the smg-1 or smg-2 mutants when
compared to WT (Table 2 and Table S2). If from this 8% we
exclude all the events that either contain a PTC (according to the
Wormbase gene annotations) or that are not a multiple of three (so
they change the reading frame), 53% of the NMD-regulated
alternative splicing events are not obvious NMD substrates. This
high proportion of cassette exons which are not PTC substrates,
but which are affected in an NMD mutant strain, might be
secondary targets of the NMD mutations due to the mis-regulation
of splicing factors whose mRNAs are direct targets for NMD.
Alternative Splicing of Splicing Factors
It has been recently shown that the AS of splicing factors is an
important step in the global regulation of AS in mammalian cells
Gene
Stages with furthest
differences
AS ratio
(log scale)
RT-PCR
confirm
Cassette exon a
Multiple of 3?
AS ratio (N2 emb
vs. smg-1 emb)
AS ratio (N2 emb
vs. smg-2 emb)
K04F10.4_2 L1 vs. L4 2.44 no 2.62 2.15
ret-1_2 Emb vs. Ad 2.45 yes 20.34 0.79
unc-89 L1 vs. Ad 2.46 yes 20.03 20.94
F25B5.1 L1 vs. L4 2.51 yes 20.87 20.87
daf-2 (RASE) Emb vs. L1 2.55 no 0.03 20.67
nhr-65 Emb vs. L1 2.56 + yes 1.96 0.67
C06A8.1 L1 vs. L4 2.60 no 1.09 1.36
pxf-1 L1 vs. L4 2.79 no 0.35 1.69
F45E10.1_2 L1 vs. L4 2.83 yes 20.31 0.23
tag-76 Emb vs. L1 2.91 no 20.16 21.42
F25C8.3 L1 vs. Ad 3.09 yes 0.34 20.68
Y69H2.3_2 Emb vs. Ad 3.17 + yes 20.58 21.17
hrpf-1 Emb vs. L1 4.05 + no 1.02 20.52
Total 58%
First column indicates the gene name at Wormbase. The second column shows the developmental stages showing the greatest differences in AS ratio for that gene.
‘‘RT-PCR Confirm’’ indicates those genes whose developmental alternative splicing was tested by RT-PCR, a ‘‘+’’ indicates that there is a correlation between ratios
obtained with the microarray and rations obtained by RT-PCR, and ‘‘-‘‘ indicates that no changes were detected by RT-PCR or that there is an anticorrelation (for details
see Figure 3). Cassette exon a multiple of 3: the size of the cassette exon was measured to determine possible changes in the reading frame by its inclusion/skipping.
The last two columns show the AS ratios (log scale) for alternative exon inclusion for N2 embryos vs. smg-1 mutant embryos or N2 embryos vs. smg-2 mutant embryos.
doi:10.1371/journal.pgen.1000001.t001
Table 1. cont.
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family of splicing factors, but there are also some examples of
splicing regulation of hnRNPs [42,43]. In our analysis of AS
during development we detected the AS ratio and expression
changes for 10 known and putative splicing factors (Table 3). We
found differences in the AS ratio of more than 2 log for just one of
them, W02D3.11, which encodes the C. elegans ortholog of the
human hnRNP F protein. We have registered W02D3.11 with
Wormbase as hrpf-1. The hnRNP F/H proteins are a family of
well-studied splicing factors that are known to silence exon
inclusion by binding to G rich sequences [44,45]. Previous work in
C. elegans has shown that hrpf-1 together with two other known
splicing factors, unc-75 and exc-7, are localized to subnuclear
speckles. hrpf-1 is expressed in all cell types unlike unc-75 and exc-7,
which are neuronal-specific [46]. Alternative splicing of hrpf-1 by
skipping exon 5 leads to a shorter transcript which still encodes
two of the three RRMs but which contains a PTC in exon 6
(Figure 4A). RT-PCR analysis during development shows that
hrpf-1 alternative splicing has a strong regulation in L1 compared
to any other stage as suggested by the microarray results
(Figure 4B). To further validate the effect of NMD on hrpf-1 we
compared RT-PCR products of N2 and smg-1 mutant embryonic
RNA for this gene. Figure 4C shows that there is a significant
difference (,30% in N2 vs. ,90% in smg-1) in the relative steady
state levels of messages showing skipping of exon 5 of hrpf-1 in
embryos of NMD defective worms. This indicates that the
skipping isoform is a target for NMD and that alternative splicing
skips this exon more often than we can measure in the steady state
mRNA level of N2 animals. In addition, since the exon inclusion
isoform is not a likely substrate for NMD, its absence in L1 is
indicative of a dramatic change in alternative splicing. This strong
regulation of a splicing factor allows us to hypothesize that hrpf-1
Figure 2. Cluster of top changes. AS ratios showing greater than four-fold differences during development were clustered using hierarchical
clustering and TreeView [68,69]. Positive AS ratios correspond to cassette exons with higher inclusion in embryos, negative AS ratios correspond to
higher inclusion in any of the other stages. A and B are two clusters of events with lower and higher inclusion in embryos respectively.
doi:10.1371/journal.pgen.1000001.g002
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that occur in the transition from embryos to subsequent stages. Its
own alternative splicing must be tightly regulated in L1, and an
understanding of the regulation of the splicing switch of hrpf-1 will
be important to pursue.
In total, our analysis of the NMD defective worms show that at
least three of the splicing factors studied have drastic changes in
AS, hrpf-1, swp-1 and rsp-6 (Table 3). Several other splicing factors,
including other SR proteins are known to be targeted by NMD
[27]. While the differences in AS detected using the microarray in
the current work for hrpf-1 are not as dramatic as the ones found
for swp-1 and rsp-6, it does show a difference (1.02 log scale) with
more skipping of the cassette exon in the NMD defective worms,
in accordance with the semi-quantitative RT-PCR results which
show a 3-fold increase in exon skipping (Figure 4C).
To further characterize the developmental regulation of the AS
of hrpf-1, we asked whether this change is evolutionarily conserved
by assaying the levels of splicing for the C. briggsae homolog of C.
elegans hrpf-1. It is estimated that C. elegans and C. briggsae derived
from a common ancestor 100 million years ago [47]. The
alternatively spliced cassette exon of hrpf-1 in the C. briggsae
homolog has 70% identity with C. elegans, and is 3 bp longer than
the C. elegans exon. As can be seen in Figure 4D, the same type of
developmental regulation, where the inclusion isoform is down-
regulated in L1s, was detected for C. briggsae. The inclusion of the
alternative spliced exon goes from 67% in embryos to 48% in L1.
While this change is clearly not as dramatic as the one found in C.
elegans, it does change the major isoform at this developmental
stage from exon inclusion to skipping.
Alternative Splicing Regulation by hnRNP F/H Splicing
Factors
There are three homologs of the mammalian hnRNP F/H
splicing factor proteins in C. elegans; hrpf-1, sym-2, and Y73B6BL.33
(Figure 5A). All three contain three highly conserved RNA
recognition motif (RRM) type RNA binding domains. sym-2 was
identified by its synthetic lethality with mutations in another
splicing factor, mec-8 [48]. RNAi of Y73B6Bl.33 results in
embryonic lethality, suggesting that this factor regulates the
splicing of an essential gene [49].
In order to investigate the role of hnRNP F/H splicing factors in
the regulation of alternative splicing, we analyzed global
alternative splicing using the splicing-sensitive DNA microarray
comparing RNA extracted from wild type and sym-2(mn617)
mutant embryos. We chose to study splicing in sym-2 mutant
embryos for two reasons. First, the availability of a viable mutant
meant that we could obtain the large quantities of synchronized
RNA necessary for dye-labeling for the microarrays. Second,
because sym-2 shows higher expression levels in embryos than in
L1s [50], alternative splicing changes in the mutant embryos might
allow for a correlation with some of the dramatic alternative
splicing changes we observed in the embryo to L1 transition in
wild type animals. In comparing N2 and sym-2(mn617) embryo
RNA on the DNA microarray, we observed 65 changes in AS
ratios that were greater than 2-fold (Table S3). One striking result
was that 6 of the 14 AS events with .4-fold changes in AS during
the embryo to L1 transition showed changes in sym-2 mutant
embryos relative to wild type embryos that mimicked the wild type
L1 splicing (Table 4). These changes were all in the same direction
and strikingly close in magnitude as measured by the array. For
example, twk-31 changes +2.41 (log scale) between embryos and
L1 in wt animals and it changes +2.34 between N2 embryos and
sym-2(mn617) embryos. For these six genes, expression of wild type
sym-2 in embryos appears to account for the splicing difference
between embryos and L1. There are an additional seven genes
whose alternative splicing both shows dramatic changes during
development (but not at the embryo to L1 transition) and whose
alternative splicing appears to be regulated by sym-2 (Table 4).
Only two of these seven genes, ser-7 between embryo and L3
and D2024.5 between L1 and adult, have alternative splicing
changes during development that move in the same direction as
the sym-2 mutant embryos compared to wt embryos. Therefore
7 of the 8 genes whose alternative splicing in sym-2 mutant
embryos changes in the same direction as the change during
development show one of the two extremes of its developmental
splicing regulation in embryos. These data are consistent with
sym-2 having its most important developmental role in
embryonic splicing. Among the genes regulated by sym-2 (Table
S3) are two splicing factors, hrpf-1 and rnp-6. rnp-6 is the C.
elegans homolog of the drosophila HALF-PINT splicing factor
[51]. The changes in alternative splicing for these two genes
between N2 embryos and sym-2(mn617) embryos were con-
firmed by semi-quantitative RT-PCR (Figure 5B), consistent
with a model in which splicing factors regulate the splicing of
additional splicing factors during development.
One of the genes with the most similar AS regulation to hrpf-1 is
top-1; both show dramatic decreases in exon inclusion during the
embryo to L1 transition. According to the microarray analysis of
sym-2 mutant embryos, top-1 is not strongly regulated by sym-2.W e
decided to ask if top-1 alternative splicing was potentially regulated
by hrpf-1. To do this we targeted hrpf-1 for reduction by RNAi
feeding of N2 worms with E. coli bacteria expressing double-
stranded RNA for a region of hrpf-1. We also used an E. coli control
strain for RNAi feeding that carried only the empty plasmid vector
L4440. We isolated RNA from embryos and compared the level of
mRNA for hrpf-1 and a control gene, lin-10, between the two
differentially fed worm populations. We used the methods
established by Caceres and colleagues to estimate the reduction
Figure 3. RT-PCR validations of microarray results. From the group
of 32 events with AS ratios changes greater than four-fold in development
when compared to embryos, 14 events were randomly selected for further
confirmationbyRT-PCR.ASratiosobtainedwiththemicroarray(darkgrey),
are compared to AS ratios obtained by RT-PCR (light grey).
doi:10.1371/journal.pgen.1000001.g003
AS Regulation During C. elegans Development
PLoS Genetics | www.plosgenetics.org 7 2008 | Volume 4 | Issue 2 | e1000001in hrpf-1 mRNA levels under these RNAi conditions [20]. As
shown in Figure 5C, we were able to achieve a modest 60%
reduction in hrpf-1 levels relative to lin-10 under hrpf-1 RNAi
conditions. We then looked at whether this change led to changes
in top-1 alternative splicing. We consistently detected a 30%
relative decrease in top-1 exon inclusion in hrpf-1 RNAi embryos
relative to a control RNAi feeding (a drop from inclusion in 34.9%
of top-1 messages in the no RNAi control embryos to 24.3%
inclusion in hrpf-1 RNAi embryos) (Figure 5D). Obtaining this
modest yet consistent change in alternative splicing with partial
removal of hrpf-1 messages by RNAi is consistent with a model in
which hrpf-1 may play a role in splicing regulation. Changes in
hrpf-1 alternative splicing to an NMD substrate isoform during the
embryo to L1 transition may account for some of the alternative
splicing changes at this stage of development.
Discussion
Here we report the first large scale analysis of alternative
splicing during C. elegans development. Previous studies had
demonstrated strong regulation of AS for a small number of
individual genes during C. elegans development [15–17]. In this
present work we sought to gain further understanding of the global
regulation of AS during development. To achieve this we designed
a splicing-sensitive microarray to detect the splicing levels for 352
cassette exons. To validate our splicing-sensitive microarray we
used RT-PCR of selected individual genes. With the assumption
that the original gene models are accurate, our platform has a
validation rate of ,70% for the detection of changes in AS. This
allows us to draw some general conclusions from our microarray
studies.
During worm development there are many morphological
changes that must occur, including the generation of new tissue
types and the increase in size of already existing tissues [14]. A
change in the mRNA isoform proportions as detected by the array
can be due to a change in the global regulation of AS for a specific
gene in many cell types or overrepresentation of particular tissues
at specific stages in which that gene undergoes cell type-specific
alternative splicing. In both cases, the factors that regulate these
splicing events will also have differential representation at the
Table 2. Top changes in AS in NMD defective strains.
Gene N2 vs. smg-1(r861) N2 vs. smg-2(e2008) PTC
Cassette exon a
Multiple of 3?
Y55F3AM.3_2 22.39 21.81 no yes
Akt-1 2.2 20.25 yes no
Lec-3 21.35 22.66 yes yes
F25B5.7 22.22 21.8 yes no
Unc-43 22.23 0.21 yes no
Rsp-6 22.11 22.93 yes no
C05D12.3 2.04 1.86 yes no
C27A7.5 2.44 20.03 yes no
K04F10.4_2 2.62 2.15 yes no
Swp-1 22.82 22.08 yes no
Y79H2A.3 22.39 20.97 yes no
Y5H2B.2 1.88 3.1 yes no
Frm-4 22.35 22.57 no yes
C36B1.12 2.16 0.82 no yes
F36H1.2 2.11 1.74 no yes
T08G11.1 22.12 21.16 no yes
T01G1.1 2.6 0.73 no yes
H14E04.2 2.52 2.24 no yes
F10G8.8 22.04 21.34 no no
C55F2.1 2.02 0.61 no yes
Klp-4 1.16 2.06 no yes
D1054.9 0.7 2.03 no yes
W08A12.1 20.94 22.68 no no
Y97E10AR.2 22.17 21.16 no yes
K04H4.1 1.96 2.06 no yes
Rig-5 1.85 2.02 no yes
Ret-1 1.85 2.02 no yes
Sox-2 22.18 21.75 no yes
The changes in the AS ratios (log scale) for exon inclusion for the indicated genes between N2 embryos and smg-1 mutant embryos or N2 embryos vs. smg-2 mutant
embryos are indicated. PTC, premature termination codon present in the cassette exon. Cassette exon a multiple of 3: the size of the cassette exon was measured to
determine possible changes in the reading frame by its inclusion/skipping.
doi:10.1371/journal.pgen.1000001.t002
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type.
For some alternative splicing events, a gradual change in
steady state levels of AS isof o r m si so b s e r v e db e t w e e n
subsequent developmental stages. For example, in sma-9 the
change in emb-L1 AS ratio measured in log scale is 21.24,
while the overall change in AS ratio between embryo and adult
is 22.51. We found seven AS events in total that presented this
type of gradual stepwise change between embryos and adults,
and these are reminiscent of the gradual change in mutually
exclusive exon usage observed for let-2 during development
[16]. The other major class of alternative splicing changes that
we observed showed a dramatic change in the AS ratio between
two subsequent stages (i.e. gip-1, emb-L1 with a change in AS
ratio of 24.74). In this study we found that, for the most part,
the major developmental changes in AS ratio in a single
developmental step occurred between embryo and L1 (14
events). While we did not address the functional importance of
these alternative splicing events, such strong regulation is highly
suggestive of a specific function linked to the events. Additional
experimentation to show the functions of these highly regulated
distinct isoforms will provide further information about specific
processes such as transcription or cell signaling (i.e. nhr-65 and
ser-7). These changes do not take into account that there are
indeed several morphological and molecular changes within the
stages used for this study. For example, the development of
embryos has several intermediate stages that include the
generation of new cell types as well as important molecular
events.
To gain further understanding of the regulation of AS during
development, and in light of findings that several splicing factors
are themselves regulated by AS, we examined the 10 alternative
spliced alternative splicing factors for which we had features on the
microarray (Table 3). While swp-1, etr-1, and rsp-5, showed greater
than 2-fold changes in alternative splicing ratios during develop-
ment, they paled in comparison to the dramatic 16-fold change in
AS ratios observed for hrpf-1 between the embryo and L1 stages.
Figure 4. hrpf-1 alternative splicing. (A) Gene model for AS of hrpf-1, two isoforms (a and b) are generated by either inclusion or skipping of exon
5; (B) Virtual gel of RT-PCR of hrpf-1 during C. elegans development as demonstrated on a Bioanalyzer (Agilent). The percentage of hrpf-1 messages
that are spliced to include exon 5 are plotted; (C) RT-PCR of the hrpf-1 mRNA from total embryonic RNA from NMD defective worms (smg-1(r861))
compared to wild type embryo RNA. This experiment demonstrates that hrpf-1b is degraded by NMD; (D) regulation of alternative splicing of the C.
briggsae hrpf-1 homolog (CBG04052) during development.
doi:10.1371/journal.pgen.1000001.g004
Table 3. Developmental changes in AS for splicing factors.
Gene L1 L2 L3 L4 adult PTC
smg-1(r861)
embryo
asd-1 20.13 20.68 0.36 0.65 0.74 yes 0.71
etr-1 20.38 20.72 20.30 20.35 21.29 no 0.10
hrp-1 0.33 0.12 0.12 0.02 20.18 no 0.98
hrpf-1 4.05 1.86 1.05 1.52 2.41 yes 1.02
ptb-1 20.67 20.65 20.29 20.05 20.19 no 0.06
rsp-5 20.02 0.05 20.50 21.04 0.17 yes 21.57
rsp-6 0.78 0.18 20.71 20.05 0.64 yes 22.11
rsp-7 20.70 20.26 20.75 20.31 20.22 yes 20.38
sup-12 0.49 0.03 20.24 20.66 20.31 no 21.85
swp-1 20.54 0.01 0.32 1.37 0.09 yes 22.82
The AS ratios (log scale) for exon inclusion during development for 10
alternatively spliced, alternative splicing factor RNA binding proteins are
indicated. PTC, premature termination codon. The last column indicates the AS
ratios (log scale) for N2 embryos vs. smg-1 mutant embryos for these genes.
doi:10.1371/journal.pgen.1000001.t003
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of splicing factors. In the worm genome there are three genes with
strong identity to the hnRNP F/H family: sym-2, hrpf-1 and
Y73B6BL.33. We demonstrated that sym-2 has a role in alternative
splicing regulation of many genes in embryos. One striking result
was that for 6/14 of the genes showing dramatic changes in
alternative splicing between the embryo and L1 stages, the embryo
splicing pattern is dependent on sym-2. It has previously been
shown that hnRNP F/H factors form heterodimers to regulate
alternative splicing of a particular target [52], so it is possible that
sym-2 also co-regulates targets with hrpf-1 or Y73B6BL.33. hnRNP
F/H factors in mammals have either activator or repressor activity
[52,53] and they share a similar high-affinity RNA binding
sequence [44]. Regulation of splicing by hnRNP F/H family
members can also be regulated by competing interactions with SR
proteins, whose expression is also regulated [54]. Of the three C.
elegans hnRNP F/H family members, only hrpf-1 is known to be
alternatively spliced. While it is not known whether the skipping
mRNA isoform, hrpf-1b, is translated into a protein, the protein it
encodes would lack one of the three RNA recognition motifs. This
truncated protein could potentially act to interfere with some of
the functions of the full-length protein and may lead to an
alteration in splicing of target genes. It was recently shown for the
human hnRNP F that the C-terminal qRRM is not required for
the recognition of RNA G-tracts [44]. This implies that the
truncated alternative HRPF-1b protein isoform, if stably pro-
duced, may be able to bind specifically to RNA. Future
experiments will be required to determine if the dramatic
regulation of splicing of hrpf-1 at the embryo-L1 transition is
responsible for regulation of other alternative splicing events in
addition to our demonstration by RNAi that hrpf-1 has a
regulatory role in top-1 splicing. Truncated human SR proteins
lacking the C-terminal SR domain have been shown to bind to
RNA and alter alternative splicing in vitro [55]. The NMD
substrate isoforms of rsp-4 and rsp-6 similarly encode the RRMs
and lack the SR domains. If these truncated isoforms are
translated, the proteins produced may have a similar role in
regulating alternative splicing. There will be many challenges to
work out before a true understanding of the role of hnRNP and
SR proteins in splicing can be deconvoluted, but it is clear that
both families are important regulators who are themselves highly
regulated.
Figure 5. Alternative splicing regulation by hnRNP F/H splicing factors. (A) Graphical representation of the structure of hnRNP H/F proteins
in C. elegans; (B) RT-PCR of hrpf-1 and rnp-6 in N2 and sym-2(mn617) embryos. The fraction of mRNA showing inclusion of the alternative exon is
indicated below each lane; (C) RT-PCR of hrpf-1 and lin-10 under hrpf-1(RNAi) and control RNAi conditions. Molar ratios of hrpf-1 and lin-10 mRNA
levels were calculated using a Bioanalyzer 2100; (D) RT-PCR of top-1 under hrpf-1(RNAi) and control RNAi conditions. The fraction of mRNA showing
inclusion of the alternative exon is indicated below each lane.
doi:10.1371/journal.pgen.1000001.g005
Table 4. Genes regulated by sym-2 that change AS during
development.
Gene
Stages with furthest
differences
AS ratio
(log scale)
N2 Emb vs.
sym-2(mn617) Emb
F38B7.1 Emb vs. L1 23.26 22.03
gsy-1 Emb vs. L1 23.75 22.26
hrpf-1 Emb vs. L1 4.05 3.92
T19A5.3 Emb vs. L1 22.76 22.32
twk-31 Emb vs. L1 2.41 2.34
unc-43_2 Emb vs. L1 22.63 23.59
ser-7 Emb vs. L3 22.64 22.84
D2024.5 L1 vs. Ad 2.06 2.49
exoc-8 L2 vs. Ad 2.16 22.09
rme-8 L4 vs. Ad 22.32 2.98
ret-1_2 Emb vs. Adult 2.45 22.24
gly-4 Emb vs. Adult 22.18 2.11
Y69H2.3_2 Emb vs. Adult 3.17 22.03
These 13 genes both show .4-fold changes in AS ratios during development
and .4-fold changes in N2 embryos vs. sym-2 embryos. The ‘‘stages with the
furthest difference’’ column indicates the developmental stages with the most
extreme alternative splicing differences. AS ratio (log-scale): represents the AS
ratio for the stages with the furthest differences. The last column indicates the
AS ratios (log-scale) for N2 embryos vs. sym-2 mutant embryos.
doi:10.1371/journal.pgen.1000001.t004
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for some of these highly regulated AS events, we studied the effects
of NMD mutants on AS ratios using the microarray. In Drosophila,
mutants in the NMD pathway are lethal and it has been suggested
that this toxicity in NMD-defective flies might be due to the mis-
regulation of native gene expression [31]. While mutants in the
NMD pathway are viable in C. elegans, our results show that NMD
coupled to alternative splicing leads to .4-fold changes in the
relative steady-state levels of isoforms of a high percentage of genes
(8% of AS events). This result allows us to suggest that the coupling
of alternative splicing with NMD is an important step in gene
regulation during C. elegans development. It is also interesting that
several splicing and transcription factors are regulated by
alternative splicing and NMD during development and that some
of the genes with the most dramatic changes in AS ratios in NMD-
defective embryos are themselves not substrates for NMD. This
implies that transcripts encoding splicing factors that are targets
for NMD (hrpf-1, swp-1, sup-12, rsp-6), may be stabilized and
translated into proteins with dominant negative effects on splicing
if the NMD pathway is defective (Table 3). This may explain why
,60% of the genes whose AS ratios changed .4-fold in an NMD
mutant background are not obvious substrates for NMD
regulation and it is also interesting to note that many predicted
substrates for NMD regulation do not show dramatic changes in
the relative steady-state levels of isoforms in NMD mutant
backgrounds. Previous reports have suggested that the activation
of NMD in C. elegans does not require splicing and it has been
suggested that rare codons may help to activate the process
[30,56,57]. It is clear that more experiments need to be done to
understand the rules for activation of NMD in C. elegans. Another
point to consider is that there are no known phenotypes associated
with early development in C. elegans NMD mutants. This seems to
indicate that this organism in laboratory growth conditions, at
least at the early stages of development, can tolerate changes in
relative steady state levels of the isoforms of many genes with no
detectable phenotypic abnormalities.
One potential role of the linkage of AS and NMD in C. elegans is
to alter the relative expression of genes that belong to the same
operon and thus share the same promoter. For example hrpf-1 is
part of an operon that includes two other genes, W02D3.10 and
unc-37. Results presented here show that in L1s there is a dramatic
reduction in the relative levels of hrpf-1a isoform to less than 10%
of the hrpf-1 transcripts. Expression microarrays from several
groups show that the hrpf-1-containing operon has a reduction of
around 75% between embryos and L1 [50,58]. While this
reduction affects all three genes in the operon, the regulation of
hrpf-1 is even stronger by the fact that, assuming that hrpf-1a is the
functional isoform, its expression goes from ,70% of the
transcripts in embryos to ,10% in L1 (Figure 6). This drastic
reduction in the generation of hrpf-1a by AS might allow unc-37
and W02D3.10 to maintain basal levels of expression in L1s, while
the levels of functional hrpf-1 are much more highly reduced.
Developmentally controlled changes in the alternative splicing
of alternative splicing factors might initiate a cascade of events that
would induce a global effect on gene expression in C. elegans. This
has been observed in sexual development in drosophila where the
sex determination pathway depends on the regulation of
alternative splicing of splicing factors at subsequent steps [59].
We demonstrate here that among the genes whose AS events show
the most dramatic changes during development there is a splicing
factor. We also show that this AS event is coupled to NMD and in
that way the strong gene regulation during development is
enhanced. Further studies of the effects that hrpf-1 has on
downstream alternative splicing targets (in addition to top-1) and
identification of the primary and secondary effects of changes in
splicing factor regulation will be the next challenges. Future work
will be aided by knowledge of the preferred RNA binding sites for
the regulated splicing factors on evolutionarily conserved splicing
regulatory regions of the primary transcripts.
Methods
Alternative Splicing Microarray
BWe previously reported 449 examples of genes with strong
cDNA evidence for alternative spliced cassette exons in the C.
elegans genome [32]. These, together with the 50 predictions made
with the Recognition of Alternatively Spliced Exons in C. elegans
algorithm, were used for the array [34]. For this work we designed
microarray probes for all the cassette exons where it was possible
to design a junction probe that will be specific for the skip isoforms
(i.e. single cassette exons), and where OligoPicker [60] was able to
accurately design a probe for that region. We found 352
alternative cassette exons that pass these criteria (Table S1). Our
general methodology for probe design can be seen in Figure 1. In
brief, we designed 40 bp probes to detect the cassette exon, the
junction created by the skipping of the cassette exon, and two
constitutive probes for each gene analyzed. The junction probes
are centered on the exon-exon junction with 20 bp in each exon.
Probes were resuspended in Pronto spotting solution (Corning) at a
concentration of 50 mM and robotically spotted onto Epoxide
slides (Corning) according to the manufacturer recommendations.
Each probe was spotted either four or six times on each slide. The
fact that each junction probe has half of its length with perfect
complementarity to two different exons that are used in both the
skipped and included isoforms creates the possibility of hybridiza-
tion to both isoforms. This problem has been previously addressed
and solved by other array designers. This led us to choose 40 bp
oligonucleotides centered on the skipping isoform splice junction
as under these hybridization conditions they can discriminate true
exon-exon junctions with continuous 40 bp complementarity from
skipping isoforms with two 20 bp complementary regions [61,62].
Probes sequence and raw data are available upon request.
RNA and DNA Samples
Bristol N2, AF16 (C. briggsae), TR1331 (smg-1(r861)), CB4043
(smg-2(e2008); him-5(e1490)) and SP2230 (sym-2(mn617)) lines
were obtained from the Caenorhabditis Genetics Center. Large
Figure 6. Correlation between steady-state mRNA levels and
AS for hrpf-1. Relative levels of hrpf-1 mRNA during development
were derived from published microarray data [58] and alternative
splicing levels were determined from our microarray data in Table 1. By
regulating the AS of hrpf-1, C. elegans is able to further down-regulate
the functional transcripts of this gene encoding the full-length, three
RRM isoform of this protein in L1 animals.
doi:10.1371/journal.pgen.1000001.g006
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with HB101 until plates were confluent; at that point worms were
synchronized using 1% sodium hypochlorite and 0.5 M NaOH to
isolate embryos. Embryo samples were taken after axenization of
adults from mixed-stage cultures. Larval and adult stages were
synchronized from embryos that we let hatch overnight inM9 buffer
at room temperature as previously reported [63]. The next morning
synchronized L1s were washed in fresh M9 and plated onto egg-
NGM plates with HB101. Samples were collected at 3 hours (L1),
12 hours (L2), 22 hours (L3), 32 hours (L4) and 48 hours (gravid
adults) at 25C. RNA samples were extracted with Trizol reagent
according to the manufacturer recommendations (Invitrogen), and
further purified using RNeasy columns (Qiagen).
Hybridizations
20 mg of purified RNA per channel were labeled with Alexa
Fluor dyes (555 and 647) using the SuperScript Indirect Labeling
System (Invitrogen) according to the manufacturer recommenda-
tions for each of the developmental stages of N2 worms as well as
for smg-1, smg-2 and sym-2 mutant embryos. Development
hybridizations were done in a loop design, with each stage
hybridized a total of four times (Figure 1) (i.e. embryo vs. L1, L1
vs. embryo, embryo vs. adult and adult vs. embryo). Hybridiza-
tions were done in duplicate with dye swaps. Labeled samples were
hybridized to slides for 14–16 hours in 20% formamide, 56SSC,
0.1% SDS and 0.1 mg/ml sheared salmon sperm DNA. Following
hybridization, the slides were washed and dried prior to scanning
with an Axon Instruments 4000 series scanners.
Data Analysis
Data were normalized and further processed using R and
Bioconductor [64]. Specifically, Limma ‘‘rma’’ background
correction was used to avoid blow out of M-values at low
intensities, median normalization was used before differential
expression analysis was done with lmFit [65,66]. Alternative
splicing ratios (AS ratios) were calculated as described in Figure 1,
[65] and [62]. For comparisons where the RNA samples were not
directly compared in the experiments (i.e. embryo vs. L2), the ratio
of the probes was calculated by using Limma Contrast Matrix
function [65]. Tables containing the AS ratios for all the genes in
all experiments are available as Tables S1 and S2.
RT-PCR
cDNAs from 5 mg RNA samples were synthesized in 20 ml
reaction mixtures using oligo dT primers and SuperScript III
enzyme according to the manufacturer recommendations (Invitro-
gen). PCR primers to detect both the inclusion and skipping isoform
were designed for the genes indicated in text (primers available on
request).2 mlofthe cDNAreactionmixturewasused asthetemplate
in 25 ml PCR reaction mixtures. Reaction mixtures were incubated
between 27–32 cycles at temperatures corresponding to each primer
set. PCR products were analyzed using anAgilent Bioanalyzer 2100,
with the Agilent DNA 1000 kit. AS ratios and inclusion proportions
were calculated from the molar concentrations of each isoform as
reported by the Bioanalyzer 2100 software (Agilent).
RNAi
RNAi by feeding was performed as previously described [67]. A
region covering the first 1000 bp of hrpf-1 was amplified from
cDNA (Fwd primer: TCTCGAGGATCAGGCATTCT; rev
primer: AGGCCACTGAACAGGAGCTA) and later cloned into
the L4440 feeding vector. Plasmids were transformed into
bacterial strain HT115. Plates containing 50 mg/ml carbenicillin
and 0.1 mM IPTG were seeded with the corresponding
transformed HT115 strain (either empty L4440 as control or
hrpf-1+L4440). Worms were transferred to IPTG/Carbenicillin
plates and let grown for seven days. Collected worms were
synchronized as described above. RNAi efficiency was measured
by comparing the levels of mRNA for hrpf-1 and a control gene,
lin-10, between the two differentially fed worm populations by
using semi-quantitative RT-PCR. Molar ratios were calculated
using the molar concentration obtained with a Bioanalyzer 2100
as described for the RT-PCR experiments.
Supporting Information
Figure S1 AS events predicted by RASE in the top 62 changes.
Found at: doi:10.1371/journal.pgen.1000001.s001 (1.96 MB EPS)
Table S1 AS ratios during development for all 352 events
studied.
Found at: doi:10.1371/journal.pgen.1000001.s002 (0.05 MB
XLS)
Table S2 AS ratios between smg-1, smg-2 and WT for all 352
events studied.
Found at: doi:10.1371/journal.pgen.1000001.s003 (0.06 MB
XLS)
Table S3 AS ratios between sym-2 and WT the top 65 genes.
Found at: doi:10.1371/journal.pgen.1000001.s004 (0.02 MB
XLS)
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